GlobalData on MSN23d
Semaglutide shortage ends as FDA sets deadline for compounders
With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions are no longer allowed – for now.
Yahoo Finance23d
Semaglutide shortage ends as FDA sets deadline for compounders
Novo Nordisk has been busy scaling its manufacturing ... limelight earlier this month with its controversial Super Bowl advert – offers compounded semaglutide. Shares in the company tumbled ...
Daily Mail26d
'Godzilla' weight loss jab that's even more effective than Ozempic has alarming downside
By comparison, trials pivotal to getting Novo Nordisk's semaglutide — the ingredient ... offering samples for as little as 80p per dose. Adverts list it as a 'weight loss supplement', with ...
Daily Record22d
Weight loss drugs linked to dozens of deaths as NHS warns about side effects
We also treat our community members to special offers, promotions, and adverts from us and our partners ... The Independent A spokesperson for Novo Nordisk, the maker of Ozempic, Rybelsus ...
Fierce Pharma2d
Novo Nordisk accepted back into UK pharma group after ‘sustained improvements’ get suspension lifted
Novo Nordisk has been accepted back into the fold. Two years after suspending Novo, the Association of the British ...
Data on new Novo Nordisk obesity drug disappoints in trial, shares drop
Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...
Novo Nordisk shares fall 6.3% after latest trial results for its next-generation weight loss drug
Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its ...